Full Episode
Friday, Sep 5
PBS NewsHour
  • Episodes
  • Podcasts
  • Newsletters
  • The Latest
  • Politics
    Politics
    • Brooks and Capehart
    • Politics Monday
    • Supreme Court
  • Arts
    Arts
    • CANVAS
    • Poetry
    • Now Read This
  • Nation
    Nation
    • Supreme Court
    • Race Matters
    • Essays
    • Brief But Spectacular
  • World
    World
    • Agents for Change
  • Economy
    Economy
    • Making Sen$e
    • Paul Solman
  • Science
    Science
    • The Leading Edge
    • ScienceScope
    • Basic Research
    • Innovation and Invention
  • Health
    Health
    • Long-Term Care
  • Education
    Education
    • Teachers' Lounge
    • Student Reporting Labs
  • For Teachers
    Education
    • Newshour Classroom
  • About
    • Feedback
    • Funders
    • Support
    • Jobs

We're not going anywhere.

Stand up for truly independent, trusted news that you can count on!
Donate now
PBS News

Get news alerts from PBS News

Turn on desktop notifications?

vaccine trials

  • Full Episodes
  • Podcasts
  • Newsletters
  • Live

Health Mar 25

AstraZeneca confirms strong vaccine protection after U.S. rift

By Lauran Neergaard, Associated Press

Health Nov 16

Watch 3:58
What it’s like to be part of a COVID-19 vaccine trial

With Moderna reporting encouraging early results from its COVID-19 vaccine candidate, we take a personal look at what it’s like to be part of the research process. The NewsHour’s John Yang is participating in Moderna’s clinical trials. He joins Judy…

Health Oct 23

AstraZeneca, Johnson & Johnson resume U.S. tests of COVID-19 vaccines

Two drugmakers say they have the go-ahead to resuming U.S. testing of their COVID-19 vaccine candidates. Both are in the final stage of testing before the companies can seek regulatory approval.

By Linda A. Johnson, Associated Press

Health Sep 15

As threat of valley fever grows beyond the Southwest, push is on for vaccine

Valley fever is diagnosed in the range of 10,000 to 15,000 cases a year in the U.S. with 160 fatalities, though both numbers are likely several times higher in reality because many cases are never identified.

By Jim Robbins, Kaiser Health News

Support Provided By: Learn more

web ad

Educate your inbox

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

Form error message goes here.

Thank you. Please check your inbox to confirm.

Full Episode
Friday, Sep 5
  • BDO
  • BNSF Railway
  • Consumer Cellular
  • Raymond James
  • Viewers Like You
  • Friends of the News Hour
PBS News

© 1996 - 2025 NewsHour Productions LLC. All Rights Reserved.

PBS is a 501(c)(3) not-for-profit organization.

Sections

  • The Latest
  • Politics
  • Arts
  • Nation
  • World
  • Economy
  • Science
  • Health
  • Education

About

  • About Us
  • TV Schedule
  • Press
  • Feedback
  • Funders
  • Support
  • Newsletters
  • Podcasts
  • Jobs
  • Privacy
  • Terms of Use

Stay Connected

  • Facebook
  • YouTube
  • Instagram
  • X
  • TikTok
  • Threads
  • RSS

Subscribe to Here's the Deal with Lisa Desjardins

Form error message goes here.

Thank you. Please check your inbox to confirm.

Support our journalism

Support for News Hour Provided By

  • BDO
  • BNSF Railway
  • Consumer Cellular
  • Raymond James
  • Viewers Like You